000 01392 a2200373 4500
005 20250517120724.0
264 0 _c20170206
008 201702s 0 0 eng d
022 _a1941-9260
024 7 _a10.1080/00325481.2016.1243005
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKushner, Pamela A
245 0 0 _aHypertriglyceridemia: the importance of identifying patients at risk.
_h[electronic resource]
260 _bPostgraduate medicine
_cNov 2016
300 _a848-858 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aCardiovascular Diseases
_xepidemiology
650 0 4 _aDiabetes Mellitus, Type 2
_xepidemiology
650 0 4 _aHumans
650 0 4 _aHydroxymethylglutaryl-CoA Reductase Inhibitors
_xtherapeutic use
650 0 4 _aHypercholesterolemia
_xblood
650 0 4 _aHypertriglyceridemia
_xdrug therapy
650 0 4 _aHypolipidemic Agents
_xtherapeutic use
650 0 4 _aLife Style
650 0 4 _aNon-alcoholic Fatty Liver Disease
_xepidemiology
650 0 4 _aPancreatitis
_xepidemiology
650 0 4 _aRacial Groups
650 0 4 _aRenal Insufficiency
_xepidemiology
650 0 4 _aRisk Factors
650 0 4 _aWeight Loss
700 1 _aCobble, Michael E
773 0 _tPostgraduate medicine
_gvol. 128
_gno. 8
_gp. 848-858
856 4 0 _uhttps://doi.org/10.1080/00325481.2016.1243005
_zAvailable from publisher's website
999 _c26489973
_d26489973